ストックスクリーナーアプリを入手
20.06
8.82%
-1.94
アフターアワーズ：
20.30
0.24
+1.20%
Alamar Biosciences Inc (ALMR) 最新ニュース
Number of shareholders of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Alamar Biosciences, Inc. (ALMR) Net Income (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Financing (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Liabilities - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash Equivalents (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Enterprise Value - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Financing (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Return On Equity (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Return On Assets (TTM) - Zacks Investment Research
This Southwest Gas Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
A Quick Look at Today's Ratings for Alamar Biosciences(ALMR.US), With a Forecast Between $27 to $35 - Moomoo
Stifel Initiates Alamar Biosciences at Buy With $28 Price Target - marketscreener.com
Leerink Initiates Alamar Biosciences at Outperform With $35 Price Target - marketscreener.com
Alamar Biosciences, Inc. (ALMR) Market Cap - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Operations (TTM) - Zacks Investment Research
Stifel initiates Alamar Biosciences stock with buy rating - Investing.com UK
JPMorgan initiates Alamar Biosciences stock with overweight rating By Investing.com - Investing.com Nigeria
JPMorgan initiates Alamar Biosciences stock with overweight rating - Investing.com India
Stifel initiates Alamar Biosciences stock with buy rating By Investing.com - Investing.com India
Alamar Biosciences, Inc. (ALMR) Gross Margin (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Assets (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Long Term Debt (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Free Cash Flow (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Dividend Yield (TTM) - Zacks Investment Research
Alamar Biosciences Revenue Jump And IPO Spotlight Neuro Focus Potential - Sahm
Alamar Biosciences, Inc. (ALMR) Ps Ratio (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Revenue (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Net Income (TTM) - Zacks Investment Research
ALMR: Alamar Biosciences, Inc.Price & Consenus Chart - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Free Cash Flow (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Profit Margin (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Price To Cash Flow - Zacks Investment Research
Alamar Biosciences Q1 Loss Widens, Revenue Rises - Moomoo
Alamar Biosciences 1Q Rev $26M >ALMR - Moomoo
Alamar Biosciences, Inc. 1Q 2026: Revenue $26.04M, EPS $(1.74) — 10-Q Summary - TradingView
ALMR SEC FilingsAlamar Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan
Alamar Biosciences Reports First Quarter 2026 Financial Results - The Manila Times
Earnings Flash (ALMR) Alamar Biosciences Posts Q1 Net Loss $1.74 a Share - marketscreener.com
Alamar Biosciences (Nasdaq: ALMR) posts 99% Q1 2026 revenue growth - Stock Titan
Earnings Flash (ALMR) Alamar Biosciences, Inc. Reports Q1 Revenue $26.0M - marketscreener.com
Fresh off a $220M IPO, Alamar expands neuro tests and posts $26M quarter - Stock Titan
Alamar Biosciences (ALMR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
ALMR Technical Analysis & Stock Price Forecast - Intellectia AI
Proteomics firm Alamar climbs 40% after upsized IPO - MSN
Investors can watch Alamar's BofA Healthcare Conference webcast May 12 - Stock Titan
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference - GlobeNewswire
Alamar Biosciences to present at BofA Securities 2026 Healthcare Conference on May 12 - Pluang
Alamar Biosciences Inc - Reuters
Alamar Biosciences Index Debut And Shelf Filing Reshape Investor Tradeoffs - Sahm
Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026 - The Manila Times
0.22%
1.41%
大文字化:
|
ボリューム (24 時間):